Overview

Comparing IM vs. Vaginal Progesterone for Pre-term Birth

Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
This is a randomized controlled trial comparing weekly intramuscular injection of 17 alpha hydroxylprogesterone caproate with daily vaginal progesterone in women with singleton pregnancies and history of prior spontaneous preterm birth in terms of maternal, fetal and neonatal outcomes. Our aim is to assess the effects on maternal, fetal and neonatal outcomes of antenatal progesterone administered intramuscularly versus vaginally in women with singleton pregnancy and a history of prior preterm birth.
Phase:
N/A
Details
Lead Sponsor:
University of Oklahoma
Treatments:
11-hydroxyprogesterone
17 alpha-Hydroxyprogesterone Caproate
17-alpha-hydroxy-progesterone caproate
Progesterone